OncoVAX (autologous cancer vaccine)
/ Vaccinogen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 11, 2020
Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews.
(PubMed, BMJ Open)
- "Recently, two autologous cell vaccines Vigil and OncoVAX have made it to phase III clinical trials...Results will be submitted to peer-reviewed journals for publication and presented to relevant stakeholders and scientific meetings. CRD42019140187."
Journal • Retrospective data • Review • Hematological Disorders • Hematological Malignancies • Oncology
1 to 1
Of
1
Go to page
1